Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2017-2028

2.1.2 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Segment by Type

2.2.1 BMS-906024

2.2.2 Buparlisib Hydrochloride

2.2.3 FP-1039

2.2.4 Ipilimumab

2.2.5 JNJ-42756493

2.2.6 Lenvatinib

2.2.7 Others

2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type

2.3.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Squamous Non-Small Cell Lung Cancer Therapeutics Segment by Application

2.4.1 Research Center

2.4.2 Hospital

2.4.3 Clinic

2.5 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application

2.5.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2022)

3 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Player

3.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Players

3.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Squamous Non-Small Cell Lung Cancer Therapeutics by Regions

4.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth (2017-2022)

4.3 APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth (2017-2022)

4.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)

5.2 Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)

5.3 Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022)

6.2 APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)

6.3 APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics by Country (2017-2022)

7.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)

7.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Squamous Non-Small Cell Lung Cancer Therapeutics Forecast

10.1.3 APAC Squamous Non-Small Cell Lung Cancer Therapeutics Forecast

10.1.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Forecast

10.1.5 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Forecast

10.2 Americas Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.2.2 Canada Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.2.3 Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.2.4 Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.3 APAC Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Region (2023-2028)

10.3.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.3.2 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.3.3 Korea Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.3.4 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.3.5 India Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.3.6 Australia Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.4.2 France Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.4.3 UK Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.4.4 Italy Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.4.5 Russia Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.5 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.5.2 South Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.5.3 Israel Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.5.4 Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.5.5 GCC Countries Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

10.6 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Type (2023-2028)

10.7 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Ascenta Therapeutics, Inc.

11.1.1 Ascenta Therapeutics, Inc. Company Information

11.1.2 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Ascenta Therapeutics, Inc. Main Business Overview

11.1.5 Ascenta Therapeutics, Inc. Latest Developments

11.2 AstraZeneca Plc

11.2.1 AstraZeneca Plc Company Information

11.2.2 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 AstraZeneca Plc Main Business Overview

11.2.5 AstraZeneca Plc Latest Developments

11.3 AVEO Pharmaceuticals, Inc.

11.3.1 AVEO Pharmaceuticals, Inc. Company Information

11.3.2 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 AVEO Pharmaceuticals, Inc. Main Business Overview

11.3.5 AVEO Pharmaceuticals, Inc. Latest Developments

11.4 Bayer AG

11.4.1 Bayer AG Company Information

11.4.2 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Bayer AG Main Business Overview

11.4.5 Bayer AG Latest Developments

11.5 BIND Therapeutics, Inc.

11.5.1 BIND Therapeutics, Inc. Company Information

11.5.2 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 BIND Therapeutics, Inc. Main Business Overview

11.5.5 BIND Therapeutics, Inc. Latest Developments

11.6 Boehringer Ingelheim GmbH

11.6.1 Boehringer Ingelheim GmbH Company Information

11.6.2 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Boehringer Ingelheim GmbH Main Business Overview

11.6.5 Boehringer Ingelheim GmbH Latest Developments

11.7 Bristol-Myers Squibb Company

11.7.1 Bristol-Myers Squibb Company Company Information

11.7.2 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Bristol-Myers Squibb Company Main Business Overview

11.7.5 Bristol-Myers Squibb Company Latest Developments

11.8 Eli Lilly and Company

11.8.1 Eli Lilly and Company Company Information

11.8.2 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Eli Lilly and Company Main Business Overview

11.8.5 Eli Lilly and Company Latest Developments

11.9 F. Hoffmann-La Roche Ltd.

11.9.1 F. Hoffmann-La Roche Ltd. Company Information

11.9.2 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 F. Hoffmann-La Roche Ltd. Main Business Overview

11.9.5 F. Hoffmann-La Roche Ltd. Latest Developments

11.10 Five Prime Therapeutics, Inc.

11.10.1 Five Prime Therapeutics, Inc. Company Information

11.10.2 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Five Prime Therapeutics, Inc. Main Business Overview

11.10.5 Five Prime Therapeutics, Inc. Latest Developments

11.11 Genentech, Inc.

11.11.1 Genentech, Inc. Company Information

11.11.2 Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.11.3 Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Genentech, Inc. Main Business Overview

11.11.5 Genentech, Inc. Latest Developments

11.12 Incyte Corporation

11.12.1 Incyte Corporation Company Information

11.12.2 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.12.3 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Incyte Corporation Main Business Overview

11.12.5 Incyte Corporation Latest Developments

11.13 Johnson & Johnson

11.13.1 Johnson & Johnson Company Information

11.13.2 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.13.3 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Johnson & Johnson Main Business Overview

11.13.5 Johnson & Johnson Latest Developments

11.14 MacroGenics, Inc.

11.14.1 MacroGenics, Inc. Company Information

11.14.2 MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.14.3 MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 MacroGenics, Inc. Main Business Overview

11.14.5 MacroGenics, Inc. Latest Developments

11.15 Novartis AG

11.15.1 Novartis AG Company Information

11.15.2 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.15.3 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Novartis AG Main Business Overview

11.15.5 Novartis AG Latest Developments

11.16 Oncogenex Pharmaceuticals, Inc.

11.16.1 Oncogenex Pharmaceuticals, Inc. Company Information

11.16.2 Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.16.3 Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Oncogenex Pharmaceuticals, Inc. Main Business Overview

11.16.5 Oncogenex Pharmaceuticals, Inc. Latest Developments

11.17 PsiOxus Therapeutics Limited

11.17.1 PsiOxus Therapeutics Limited Company Information

11.17.2 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

11.17.3 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 PsiOxus Therapeutics Limited Main Business Overview

11.17.5 PsiOxus Therapeutics Limited Latest Developments

12 Research Findings and Conclusion

Table 1. Squamous Non-Small Cell Lung Cancer Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of BMS-906024

Table 3. Major Players of Buparlisib Hydrochloride

Table 4. Major Players of FP-1039

Table 5. Major Players of Ipilimumab

Table 6. Major Players of JNJ-42756493

Table 7. Major Players of Lenvatinib

Table 8. Major Players of Others

Table 9. Squamous Non-Small Cell Lung Cancer Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 11. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2022)

Table 12. Squamous Non-Small Cell Lung Cancer Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 13. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 14. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2022)

Table 15. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 16. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Player (2020-2022)

Table 17. Squamous Non-Small Cell Lung Cancer Therapeutics Key Players Head office and Products Offered

Table 18. Squamous Non-Small Cell Lung Cancer Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 19. New Products and Potential Entrants

Table 20. Mergers & Acquisitions, Expansion

Table 21. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 22. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Regions (2017-2022)

Table 23. Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 24. Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Country (2017-2022)

Table 25. Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 26. Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2022)

Table 27. Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 28. Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2022)

Table 29. APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 30. APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Region (2017-2022)

Table 31. APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 32. APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2022)

Table 33. APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 34. APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2022)

Table 35. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 36. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Country (2017-2022)

Table 37. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 38. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2022)

Table 39. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 40. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2022)

Table 41. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Region (2017-2022)

Table 43. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2022)

Table 45. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 46. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2022)

Table 47. Key Market Drivers & Growth Opportunities of Squamous Non-Small Cell Lung Cancer Therapeutics

Table 48. Key Market Challenges & Risks of Squamous Non-Small Cell Lung Cancer Therapeutics

Table 49. Key Industry Trends of Squamous Non-Small Cell Lung Cancer Therapeutics

Table 50. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 51. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 52. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 53. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 54. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 55. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 56. Ascenta Therapeutics, Inc. Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 57. Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 58. Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 59. Ascenta Therapeutics, Inc. Main Business

Table 60. Ascenta Therapeutics, Inc. Latest Developments

Table 61. AstraZeneca Plc Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 62. AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 63. AstraZeneca Plc Main Business

Table 64. AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. AstraZeneca Plc Latest Developments

Table 66. AVEO Pharmaceuticals, Inc. Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 67. AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 68. AVEO Pharmaceuticals, Inc. Main Business

Table 69. AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. AVEO Pharmaceuticals, Inc. Latest Developments

Table 71. Bayer AG Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 72. Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 73. Bayer AG Main Business

Table 74. Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Bayer AG Latest Developments

Table 76. BIND Therapeutics, Inc. Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 77. BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 78. BIND Therapeutics, Inc. Main Business

Table 79. BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. BIND Therapeutics, Inc. Latest Developments

Table 81. Boehringer Ingelheim GmbH Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 82. Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 83. Boehringer Ingelheim GmbH Main Business

Table 84. Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Boehringer Ingelheim GmbH Latest Developments

Table 86. Bristol-Myers Squibb Company Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 87. Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 88. Bristol-Myers Squibb Company Main Business

Table 89. Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Bristol-Myers Squibb Company Latest Developments

Table 91. Eli Lilly and Company Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 92. Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 93. Eli Lilly and Company Main Business

Table 94. Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Eli Lilly and Company Latest Developments

Table 96. F. Hoffmann-La Roche Ltd. Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 97. F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 98. F. Hoffmann-La Roche Ltd. Main Business

Table 99. F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. F. Hoffmann-La Roche Ltd. Latest Developments

Table 101. Five Prime Therapeutics, Inc. Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 102. Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 103. Five Prime Therapeutics, Inc. Main Business

Table 104. Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Five Prime Therapeutics, Inc. Latest Developments

Table 106. Genentech, Inc. Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 107. Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 108. Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 109. Genentech, Inc. Main Business

Table 110. Genentech, Inc. Latest Developments

Table 111. Incyte Corporation Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 112. Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 113. Incyte Corporation Main Business

Table 114. Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Incyte Corporation Latest Developments

Table 116. Johnson & Johnson Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 117. Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 118. Johnson & Johnson Main Business

Table 119. Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Johnson & Johnson Latest Developments

Table 121. MacroGenics, Inc. Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 122. MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 123. MacroGenics, Inc. Main Business

Table 124. MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. MacroGenics, Inc. Latest Developments

Table 126. Novartis AG Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 127. Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 128. Novartis AG Main Business

Table 129. Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Novartis AG Latest Developments

Table 131. Oncogenex Pharmaceuticals, Inc. Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 132. Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 133. Oncogenex Pharmaceuticals, Inc. Main Business

Table 134. Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. Oncogenex Pharmaceuticals, Inc. Latest Developments

Table 136. PsiOxus Therapeutics Limited Details, Company Type, Squamous Non-Small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 137. PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Product Offered

Table 138. PsiOxus Therapeutics Limited Main Business

Table 139. PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 140. PsiOxus Therapeutics Limited Latest Developments

List of Figures

Figure 1. Squamous Non-Small Cell Lung Cancer Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Type in 2021

Figure 7. Squamous Non-Small Cell Lung Cancer Therapeutics in Research Center

Figure 8. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market: Research Center (2017-2022) & ($ Millions)

Figure 9. Squamous Non-Small Cell Lung Cancer Therapeutics in Hospital

Figure 10. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market: Hospital (2017-2022) & ($ Millions)

Figure 11. Squamous Non-Small Cell Lung Cancer Therapeutics in Clinic

Figure 12. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market: Clinic (2017-2022) & ($ Millions)

Figure 13. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Application in 2021

Figure 14. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Player in 2021

Figure 15. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2017-2022 ($ Millions)

Figure 17. APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2017-2022 ($ Millions)

Figure 18. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2017-2022 ($ Millions)

Figure 20. Americas Squamous Non-Small Cell Lung Cancer Therapeutics Value Market Share by Country in 2021

Figure 21. Americas Squamous Non-Small Cell Lung Cancer Therapeutics Consumption Market Share by Type in 2021

Figure 22. Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Application in 2021

Figure 23. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Region in 2021

Figure 28. APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Application in 2021

Figure 29. China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Country in 2021

Figure 36. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Type in 2021

Figure 37. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Application in 2021

Figure 38. Germany Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Application in 2021

Figure 46. Egypt Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 52. APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 53. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Canada Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. Korea Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. Australia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. Germany Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. France Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. UK Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Italy Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. Russia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. Spain Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. Israel Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)